Famotidine Powder, For Suspension
Product Images NDC 70954-316

2 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 70954-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Famotidine Label)

Label (Famotidine Label)
Label for Famotidine 40 mg/5 mL oral suspension powder by Novitium Pharma LLC, 50 mL bottle when reconstituted. The label includes dosage information, reconstitution instructions to add 46 mL water, storage conditions, and a notice to keep medication away from children. The product is Rx only.*
FDA Label Image

Structure (Famotidine Structure)

Structure (Famotidine Structure)
Chemical structure diagram of famotidine, showing its molecular configuration with sulfur, nitrogen, oxygen, and carbon atoms arranged according to the active ingredient's known chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.